News

Search Articles

1351 - 1365 of 1450 Results Clear All

October 7, 2012

Gladstone Scientists Identify Biological Mechanism that Plays Key Role in Early-Onset Dementia

SAN FRANCISCO, CA—Using animal models, scientists at the Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD)—a form of early-onset dementia that is similar to Alzheimer’s disease.

October 7, 2012

Gladstone Scientist Wins Nobel Prize in Medicine

Shinya Yamanaka MD, PhD, a senior investigator at the Gladstone Institutes has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that, like embryonic stem cells, are capable of developing into any cell in the human body.

Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs

September 12, 2012

Gladstone Scientists Map the Genomic Blueprint of the Heart

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.

Bruneau Lab

September 11, 2012

Gladstone-Led Study Underscores Truvada’s Potency in Preventing the Transmission of HIV

SAN FRANCISCO, CA—New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV prevention.

Grant Lab HIV/AIDS

September 10, 2012

Gladstone Scientists Develop Innovative Technique to Monitor and Decipher the Dormant AIDS Virus Concealed in Cells

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

HIV/AIDS Weinberger Lab

August 5, 2012

Gladstone Scientists Discover that Epilepsy Drug Reverses Memory Loss in Animal Model of Alzheimer’s Disease

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.

Alzheimer’s Disease Epilepsy Mucke Lab

July 31, 2012

Gladstone Named Best Place to Work in Academia

SAN FRANCISCO, CA—For a second year in a row, an annual survey from The Scientist magazine has named the Gladstone Institutes as the best place to work in academia.

July 23, 2012

Jesse Dylan Film Series Spotlights Gladstone Science

SAN FRANCISCO, CA—The Gladstone Institutes has joined forces with Jesse Dylan’s award-winning film company to raise public awareness—through a series of short films—about unmet medical needs that Gladstone scientists and supporters are addressing

July 22, 2012

Gladstone’s Dr. Warner C. Greene Authors HIV/AIDS Medicine Textbook for Developing World

SAN FRANCISCO, CA—July 23, 2012—Warner C. Greene, MD, who directs virology and immunology research at the Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.

Article July 14, 2012

Gladstone’s Lennart Mucke Receives Lifetime Achievement Award from the Alzheimer’s Association

SAN FRANCISCO—July 15, 2012—Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr.

Awards Alzheimer’s Disease Mucke Lab

July 4, 2012

Gladstone Scientists Identify Critical Process in Stem Cell Development

SAN FRANCISCO, CA—July 5, 2012—Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell—called an iPS cell—that is derived from adult skin cells.

Stem Cells/iPSCs

Article June 27, 2012

Gladstone Scientists Use Stem Cell Technology to Tackle Huntington’s Disease

SAN FRANCISCO, CA—June 28, 2012—Scientists at the Gladstone Institutes and an international team of researchers have generated a human model of Huntington's disease—directly from the skin cells of patients with the disease.

Huntington’s Disease

Article June 12, 2012

Consortium of Scientists Map the Human Body’s Bacterial Ecosystem

Scientists at Gladstone Institutes today are announcing their role in an unprecedented collaboration organized by the National Institutes of Health, which used groundbreaking methods to vastly improve our understanding of bacteria that reside in and on the human body.

News Release Center for Systems and Therapeutics Pollard Lab Big Data Microbiome

June 12, 2012

Gladstone Investigator Shinya Yamanaka Receives Millennium Technology Award

SAN FRANCISCO, CA—Gladstone Institutes Senior Investigator Shinya Yamanaka, MD, PhD, has won the Millennium Technology Prize, the world's largest and most

June 6, 2012

Gladstone Scientists Reprogram Skin Cells into Brain Cells

SAN FRANCISCO, CA—June 7, 2012—Scientists at the Gladstone Institutes have for the first time transformed skin cells—with a single genetic factor—into cells that develop on their own into an interconnected, functional network of brain cells.

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media

Are You a Journalist Looking to Write about Gladstone?

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!